NPCENeuroPace, Inc.

$482M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$11M+7.9% YoY

Gross Profit

$8M71.4% margin

Operating Income

-$10M-91.4% margin

Net Income

-$12M-105.6% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$120M

Total Liabilities

$77M

Stockholders' Equity

$43M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$10M	+7.9%
Gross Profit	$8M	$8M	+6.1%
Operating Income	-$10M	-$6M	-63.4%
Net Income	-$12M	-$8M	-45.8%

NPCE Q3 2022 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena